Heptares Therapeutics


Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functiona... Read more


Org chart

Chris Cargill
Chief Executive Officer
Collapse
Candelle Chong
Executive Vice President, Chief of Staff
Hironoshin Nomura
Chief Financial Officer
Matt Barnes
President of Heptares Therapeutics Ltd. and Head of UK R&D
Matthew Foxwell
Director Of Information Technology
Shinichiro N.
Vice President, IR & Corporate Strategy Department
Takuya Saiki
Vice President Clinical Development Dept.
Mariko Nakafuji
General Counsel
Gerard Collins
Human Resources Director